Results
1 -
8 of
8Pike Kurt G., Malagu Karine, Hummersone Marc G., Menear Keith A., Duggan Heather M.E., Gomez Sylvie, Martin Niall M.B., Ruston Linette, Pass Sarah L., Pass Martin.
Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: The discovery of AZD8055 and AZD2014, Bioorganic & Medicinal Chemistry Letters, 2013 Ma Xiao-Dong, Qiu Ni, Yang Bo, He Qiao-Jun, Hu Yong-Zhou.
Novel quinoline-derived mTOR inhibitors with remarkable enzymatic and cellular activities: design, synthesis and biological evaluation, Med. Chem. Commun., 2016 Targeting autophagy to modulate cell survival: a comparative analysis in cancer, normal and embryonic cells, Histochemistry and Cell Biology EGFR-AKT-mTOR activation mediates epiregulin-induced pleiotropic functions in cultured osteoblasts, Molecular and Cellular Biochemistry Aberrant modulation of ribosomal protein S6 phosphorylation confers acquired resistance to MAPK pathway inhibitors in BRAF-mutant melanoma, Acta Pharmacologica Sinica Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma, Cellular Oncology Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer, Journal of Hematology & Oncology C. Borsari, E. Keles, A. Treyer, M. De Pascale, P. Hebeisen, M. Hamburger, M. P. Wymann.
4